Literature DB >> 12842087

Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin.

Yuki Hamano1, Michael Zeisberg, Hikaru Sugimoto, Julie C Lively, Yohei Maeshima, Changqing Yang, Richard O Hynes, Zena Werb, Akulapalli Sudhakar, Raghu Kalluri.   

Abstract

We demonstrate a physiological role for tumstatin, a cleavage fragment of the alpha3 chain of type IV collagen (Col IValpha3), which is present in the circulation. Mice with a genetic deletion of Col IValpha3 show accelerated tumor growth associated with enhanced pathological angiogenesis, while angiogenesis associated with development and tissue repair are unaffected. Supplementing Col IValpha3-deficient mice with recombinant tumstatin to a normal physiological concentration abolishes the increased rate of tumor growth. The suppressive effects of tumstatin require alphaVbeta3 integrin expressed on pathological, but not on physiological, angiogenic blood vessels. Mice deficient in matrix metalloproteinase-9, which cleaves tumstatin efficiently from Col IValpha3, have decreased circulating tumstatin and accelerated growth of tumor. These results indicate that MMP-generated fragments of basement membrane collagen can have endogenous function as integrin-mediated suppressors of pathologic angiogenesis and tumor growth.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842087      PMCID: PMC2775452          DOI: 10.1016/s1535-6108(03)00133-8

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  74 in total

Review 1.  New functional roles for non-collagenous domains of basement membrane collagens.

Authors:  Nathalie Ortega; Zena Werb
Journal:  J Cell Sci       Date:  2002-11-15       Impact factor: 5.285

Review 2.  Discovery of type IV collagen non-collagenous domains as novel integrin ligands and endogenous inhibitors of angiogenesis.

Authors:  R Kalluri
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2002

Review 3.  The diverse roles of integrins and their ligands in angiogenesis.

Authors:  R O Hynes; J C Lively; J H McCarty; D Taverna; S E Francis; K Hodivala-Dilke; Q Xiao
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2002

Review 4.  A reevaluation of integrins as regulators of angiogenesis.

Authors:  Richard O Hynes
Journal:  Nat Med       Date:  2002-09       Impact factor: 53.440

Review 5.  Endothelial cell-matrix interactions: in vitro models of angiogenesis.

Authors:  J A Madri; B M Pratt
Journal:  J Histochem Cytochem       Date:  1986-01       Impact factor: 2.479

Review 6.  Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis.

Authors:  B G Hudson; S T Reeders; K Tryggvason
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

7.  Structure and composition of type IV collagen of bovine aorta.

Authors:  G K Reddy; S Gunwar; R Kalluri; B G Hudson; M E Noelken
Journal:  Biochim Biophys Acta       Date:  1993-07-11

8.  Hydra cell aggregate development is blocked by selective fragments of fibronectin and type IV collagen.

Authors:  X Zhang; B G Hudson; M P Sarras
Journal:  Dev Biol       Date:  1994-07       Impact factor: 3.582

9.  7 S collagen: a method for the measurement of serum concentrations in man.

Authors:  B Högemann; B Voss; G Pott; J Rauterberg; U Gerlach
Journal:  Clin Chim Acta       Date:  1984-12-15       Impact factor: 3.786

10.  Basement membrane biosynthesis as a target for developing inhibitors of angiogenesis with anti-tumor properties.

Authors:  M E Maragoudakis; E Missirlis; G D Karakiulakis; M Sarmonica; M Bastakis; N Tsopanoglou
Journal:  Kidney Int       Date:  1993-01       Impact factor: 10.612

View more
  179 in total

Review 1.  Molecular targeting of angiogenesis for imaging and therapy.

Authors:  Simon S Brack; Ludger M Dinkelborg; Dario Neri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-08-05       Impact factor: 9.236

Review 2.  Regulation of matrix biology by matrix metalloproteinases.

Authors:  Joni D Mott; Zena Werb
Journal:  Curr Opin Cell Biol       Date:  2004-10       Impact factor: 8.382

3.  Genetic elimination of α3(IV) collagen fails to rescue anti-collagen B cells.

Authors:  Amy G Clark; Katherine M Mackin; Mary H Foster
Journal:  Immunol Lett       Date:  2011-09-24       Impact factor: 3.685

4.  TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis.

Authors:  Liliana Guedez; Sandra Jensen-Taubman; Dimitra Bourboulia; Clifford J Kwityn; Beiyang Wei; John Caterina; William G Stetler-Stevenson
Journal:  J Immunother       Date:  2012-07       Impact factor: 4.456

5.  Regional control of tumor growth.

Authors:  Alexander Zaslavsky; Catherine Chen; Jenny Grillo; Kwan-Hyuck Baek; Lars Holmgren; Sam S Yoon; Judah Folkman; Sandra Ryeom
Journal:  Mol Cancer Res       Date:  2010-08-24       Impact factor: 5.852

6.  E-cadherin and transglutaminase-1 epithelial barrier restoration precedes type IV collagen basement membrane reconstruction following vocal fold mucosal injury.

Authors:  Changying Ling; Jennifer L Raasch; Nathan V Welham
Journal:  Cells Tissues Organs       Date:  2010-10-20       Impact factor: 2.481

7.  Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.

Authors:  Akulapalli Sudhakar; Pia Nyberg; Venkateshwar G Keshamouni; Arjuna P Mannam; Jian Li; Hikaru Sugimoto; Dominic Cosgrove; Raghu Kalluri
Journal:  J Clin Invest       Date:  2005-09-08       Impact factor: 14.808

8.  A Novel Collagen Matricryptin Reduces Left Ventricular Dilation Post-Myocardial Infarction by Promoting Scar Formation and Angiogenesis.

Authors:  Merry L Lindsey; Rugmani Padmanabhan Iyer; Rogelio Zamilpa; Andriy Yabluchanskiy; Kristine Y DeLeon-Pennell; Michael E Hall; Abdullah Kaplan; Fouad A Zouein; Dustin Bratton; Elizabeth R Flynn; Presley L Cannon; Yuan Tian; Yu-Fang Jin; Richard A Lange; Dorota Tokmina-Roszyk; Gregg B Fields; Lisandra E de Castro Brás
Journal:  J Am Coll Cardiol       Date:  2015-09-22       Impact factor: 24.094

9.  Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.

Authors:  Michitaka Matsuda; Ekihiro Seki
Journal:  Semin Liver Dis       Date:  2020-04-02       Impact factor: 6.115

10.  Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity.

Authors:  Hans Petter Eikesdal; Hikaru Sugimoto; Gabriel Birrane; Yohei Maeshima; Vesselina G Cooke; Mark Kieran; Raghu Kalluri
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.